186 related articles for article (PubMed ID: 26805371)
21. Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.
Stokes JB; Nolan NJ; Stelow EB; Walters DM; Weiss GR; de Lange EE; Rich TA; Adams RB; Bauer TW
Ann Surg Oncol; 2011 Mar; 18(3):619-27. PubMed ID: 21213060
[TBL] [Abstract][Full Text] [Related]
22. [A resected case of pathologically complete response of a pelvic recurrence from rectal cancer after chemoradiotherapy with S-1].
Nakano D; Matsumoto H; Yamaguchi T; Iwasaki Y; Ohashi M; Iwanaga T; Takahashi K
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2137-9. PubMed ID: 20037348
[TBL] [Abstract][Full Text] [Related]
23. Tips and tricks of the surgical technique for borderline resectable pancreatic cancer: mesenteric approach and modified distal pancreatectomy with en-bloc celiac axis resection.
Hirono S; Yamaue H
J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):E4-7. PubMed ID: 25366360
[TBL] [Abstract][Full Text] [Related]
24. Locally advanced pancreatic adenocarcinoma: reassessment of response with CT after neoadjuvant chemotherapy and radiation therapy.
Cassinotto C; Mouries A; Lafourcade JP; Terrebonne E; Belleannée G; Blanc JF; Lapuyade B; Vendrely V; Laurent C; Chiche L; Wagner T; Sa-Cunha A; Gaye D; Trillaud H; Laurent F; Montaudon M
Radiology; 2014 Oct; 273(1):108-16. PubMed ID: 24960211
[TBL] [Abstract][Full Text] [Related]
25. Immunological impact of neoadjuvant chemoradiotherapy in patients with borderline resectable pancreatic ductal adenocarcinoma.
Homma Y; Taniguchi K; Murakami T; Nakagawa K; Nakazawa M; Matsuyama R; Mori R; Takeda K; Ueda M; Ichikawa Y; Tanaka K; Endo I
Ann Surg Oncol; 2014 Feb; 21(2):670-6. PubMed ID: 24310792
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant S-1 with concurrent radiotherapy followed by surgery for borderline resectable pancreatic cancer: study protocol for an open-label, multicentre, prospective phase II trial (JASPAC05).
Takahashi S; Ohno I; Ikeda M; Kobayashi T; Akimoto T; Kojima M; Konishi M; Uesaka K
BMJ Open; 2017 Oct; 7(10):e018445. PubMed ID: 29061632
[TBL] [Abstract][Full Text] [Related]
27. [A case of acinar cell carcinoma of pancreas with liver metastases treated effectively by S-1].
Morishima K; Hyodo M; Nihei Y; Sata N; Yasuda Y
Gan To Kagaku Ryoho; 2010 Jan; 37(1):127-9. PubMed ID: 20087046
[TBL] [Abstract][Full Text] [Related]
28. Phase I/II study of preoperative concurrent chemoradiotherapy with S-1 for locally advanced, resectable rectal adenocarcinoma.
Sadahiro S; Suzuki T; Tanaka A; Okada K; Kamijo A; Murayama C; Akiba T; Nakayama Y
Oncology; 2011; 81(5-6):306-11. PubMed ID: 22156392
[TBL] [Abstract][Full Text] [Related]
29. [A Case of Locally Advanced Pancreatic Cancer Showing R0 Resection after Resection of the Portal Vein Following Preoperative Chemoradiotherapy].
Nakano R; Satoh D; Tokumoto N; Chouda Y; Kanazawa T; Takada S; Harano M; Matsukawa H; Ojima Y; Idani H; Shiozaki S; Okajima M; Ninomiya M
Gan To Kagaku Ryoho; 2016 Apr; 43(4):459-61. PubMed ID: 27220794
[TBL] [Abstract][Full Text] [Related]
30. [A case of adjuvant surgery for a patient with initially unresectable locally advanced pancreatic cancer (LAPC) with a favorable response to S-1 chemotherapy].
Ueta A; Toyama H; Goto T; Matsumoto I; Shinzeki M; Asari S; Ishida J; Nanno Y; Tsugawa D; Kuramitsu K; Tanaka M; Takebe A; Okazaki T; Kido M; Ajiki T; Fukumoto T; Okuno T; Kokubun M; Ito T; Ku Y
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2178-80. PubMed ID: 25731462
[TBL] [Abstract][Full Text] [Related]
31. Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation.
Kwon D; McFarland K; Velanovich V; Martin RC
Surgery; 2014 Oct; 156(4):910-20. PubMed ID: 25239345
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of stereotactic body radiation therapy combined with S-1 simultaneously followed by sequential S-1 as an initial treatment for locally advanced pancreatic cancer (SILAPANC) trial: study design and rationale of a phase II clinical trial.
Zhu X; Ju X; Cao F; Fang F; Qing S; Shen Y; Jia Z; Cao Y; Zhang H
BMJ Open; 2016 Dec; 6(12):e013220. PubMed ID: 27909037
[TBL] [Abstract][Full Text] [Related]
33. [Examination of resectable and borderline pancreatic cancer treated with neoadjuvant chemoradiation therapy].
Mataki Y; Shinchi H; Maemura K; Kurahara H; Kawasaki Y; Desaki R; Ueno S; Sakoda M; Iino S; Higashi M; Takao S; Natsugoe S
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1637-40. PubMed ID: 24393873
[TBL] [Abstract][Full Text] [Related]
34. [Preoperative chemoradiotherapy with S-1 for advanced low rectal cancer].
Kitani K; Okajima K; Sato K; Isono S; Kimura H; Ikeda M; Inoue K; Iwama M; Tsujie M; Nakayama T; Fujiwara Y; Murata M; Yukawa M; Ota Y; Inoue M
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2122-4. PubMed ID: 22202303
[TBL] [Abstract][Full Text] [Related]
35. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
[TBL] [Abstract][Full Text] [Related]
36. Combined Analyses of hENT1, TS, and DPD Predict Outcomes of Borderline-resectable Pancreatic Cancer.
Yabushita Y; Mori R; Taniguchi K; Matsuyama R; Kumamoto T; Sakamaki K; Kubota K; Endo I
Anticancer Res; 2017 May; 37(5):2465-2476. PubMed ID: 28476815
[TBL] [Abstract][Full Text] [Related]
37. Resected tumor seeding in stomach wall due to endoscopic ultrasonography-guided fine needle aspiration of pancreatic adenocarcinoma.
Tomonari A; Katanuma A; Matsumori T; Yamazaki H; Sano I; Minami R; Sen-yo M; Ikarashi S; Kin T; Yane K; Takahashi K; Shinohara T; Maguchi H
World J Gastroenterol; 2015 Jul; 21(27):8458-61. PubMed ID: 26217099
[TBL] [Abstract][Full Text] [Related]
38. [A Case of Carcinosarcoma of the Esophagus Treated with Chemoradiotherapy].
Nakao E; Iijima S; Tsujimura N; Matsumoto T; Takemoto H; Takachi K; Nishioka K; Oshima S; Uemura Y; Yoshida K
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1905-7. PubMed ID: 26805212
[TBL] [Abstract][Full Text] [Related]
39. Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy.
Barugola G; Partelli S; Crippa S; Capelli P; D'Onofrio M; Pederzoli P; Falconi M
Am J Surg; 2012 Feb; 203(2):132-9. PubMed ID: 21824596
[TBL] [Abstract][Full Text] [Related]
40. [A long-term survivor who received S-1-based multidisciplinary therapy for unresectable advanced pancreatic cancer].
Makino H; Kametaka H; Koyama T; Seike K
Gan To Kagaku Ryoho; 2011 Dec; 38(13):2647-50. PubMed ID: 22189235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
